Detailed needs assessments

Long Term Conditions

LTC pictureImprovements in medical treatment and success in public health interventions have resulted in people having longer lives, often with some form of long-term morbidity or disability.  In England, the Department of Health estimates that over a quarter of the population have a Long Term Condition (LTC).  An increasing number of these people also have a co-morbidity (or co-morbidities) and so are in a state of Multi-Morbidity (MM).  The on-going management of LTCs and Multi-Morbidity is now a central task of the NHS and care services.

In the 2017 Joint Strategic Needs Assessment (JSNA) for Swindon, we have drawn upon existing data sources (such as the 2011 Census and QOF registers) to estimate the “LTC prevalence pool” in Swindon UA.  We have also applied the Symphony Model to the Swindon population to estimate the magnitude of groups of LTC patients and impute their activity in our local health and social care system.  Symphony is a record-linkage project, which has used “real life” health and social care data from Somerset to identify patterns of activity in a population.  We also used the model to investigate other issues relating to LTCs within Swindon, such as Multi-Morbidity, costs and the effects of deprivation.  The JSNA informs decisions about how services are commissioned and designed.

The latest prevalence data for Swindon for a range of long term conditions is collated by GP Practices and summarised in the Quality and Outcomes Framework (QOF) data collection by NHS Digital.


Liver disease

Liver disease is largely preventable, most liver disease is due to three main risk factors: alcohol, viral hepatitis and obesity.  However, most people at risk of developing serious liver disease, or who show early signs of liver damage, are not aware of the fact.  Diagnosing liver disease early and treating the cause can prevent the progress of liver disease reducing liver cancer, liver transplants and liver mortality, as well as improving quality of life.  In addition reducing alcohol misuse and injecting drug misuse can lead to wider societal cost savings.

For information and statistics on liver disease, please see the dedicated liver disease page


Further resources


JSNA Annual Summary – Long Term Conditions section

The JSNA Annual Summary contains a section on long term conditions which can be accessed below. This summary page is only updated in March each year.



Pages in this section